£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Rheumatoid Arthritis Pharma Outlook China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study analyses the latent demand outlook for rheumatoid arthritis pharmaceutical therapeutics across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions and Taiwan. The report delivers potential industry earnings (P.I.E.) estimates spanning more than 1,100 cities throughout China, providing detailed market penetration data for each major urban centre. Prepared by ICON Group International, this outlook equips pharmaceutical companies, healthcare strategists and investors with actionable intelligence on market dynamics, regional demand patterns and growth opportunities within China's rheumatoid arthritis therapeutic segment through 2028.

Key Features

Covers latent demand estimates for rheumatoid arthritis pharmaceutical therapeutics across all Chinese regions including provinces, autonomous regions, municipalities and special administrative regions.

Provides potential industry earnings (P.I.E.) forecasts for more than 1,100 cities in China to identify key market opportunities.

Analyses market share percentages by city to determine regional demand concentration and competitive positioning.

Delivers 2023-2028 outlook period data enabling multi-year strategic planning for pharmaceutical companies and healthcare investors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in India
94% match

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Rheumatology Therapeutics in India
93% match

The 2023-2028 Outlook for Rheumatology Therapeutics in India

£515.00 27 Sep 2026
2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China
90% match

2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China

£495.00 28 Sep 2026
2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
90% match

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
89% match

2023-2028 Orphan Diseases Therapeutics CNS China Outlook

£495.00 28 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
89% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
2023-2028 Chemotherapy Nausea Drug Outlook - China Market Study
89% match

2023-2028 Chemotherapy Nausea Drug Outlook - China Market Study

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
89% match

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

£495.00 28 Sep 2026
2023-2028 Injectable Drug Delivery Devices Outlook China
89% match

2023-2028 Injectable Drug Delivery Devices Outlook China

£495.00 28 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
89% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
2023-2028 Non-Opioid Pain Patches Market Outlook - China
89% match

2023-2028 Non-Opioid Pain Patches Market Outlook - China

£495.00 28 Sep 2026
2023-2028 Artificial Tears Market Outlook China - Regional Analysis
89% match

2023-2028 Artificial Tears Market Outlook China - Regional Analysis

£495.00 28 Sep 2026
2023-2028 Spinal Cord Trauma Corticosteroid Treatments Outlook China
89% match

2023-2028 Spinal Cord Trauma Corticosteroid Treatments Outlook China

£495.00 28 Sep 2026
Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028
89% match

Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028

£495.00 28 Sep 2026
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
88% match

2023-2028 Nasal Drug Delivery Outlook for China - Market Research

£495.00 28 Sep 2026
2023-2028 Compact Advance Radiotherapy Systems Outlook - China
88% match

2023-2028 Compact Advance Radiotherapy Systems Outlook - China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
2023-2028 Contraceptive Drugs Outlook for China - Market Analysis
88% match

2023-2028 Contraceptive Drugs Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
88% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in India
88% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Vasculitis Treatments in India
87% match

The 2023-2028 Outlook for Vasculitis Treatments in India

£515.00 27 Sep 2026
2023-2028 Sleeping Pills Market Outlook China - Regional Analysis
87% match

2023-2028 Sleeping Pills Market Outlook China - Regional Analysis

£495.00 28 Sep 2026
2023-2028 Oral Alopecia Drugs Outlook China - Market Analysis
87% match

2023-2028 Oral Alopecia Drugs Outlook China - Market Analysis

£495.00 28 Sep 2026